Hosted on MSN2mon
Zepbound vs. Wegovy: New clinical trial says this weight-loss medication sheds more pounds
Zepbound (tirzepatide), manufactured by Fortune 500 firm Eli Lilly & Co., bested competitor Wegovy (semaglutide), a product of Global 500 company Novo Nordisk, in a recent randomized clinical ...
Yahoo Finance1mon
Tirzepatide outpacing Wegovy in the obesity space
According to leading data and analytics company GlobalData, Eli Lilly’s Zepbound (tirzepatide) is poised to surpass Novo Nordisk’s Wegovy (semaglutide), despite expectations for continued ...